“It’s fascinating to see the U.S. obesity rate finally dropping, but are we giving too much credit to drugs like Ozempic and rising costs? I think a major factor is the massive shift in attitudes toward wellness. People are increasingly aware of the impact of lifestyle choices on long-term health. Sure, economic factors play a role, but does it really take inflation or a new ‘miracle’ drug to make us prioritize health?

Could it be that the ‘quick fixes’ — whether fad diets, surgery, or now injections — are a short-term solution to what is ultimately a lifestyle issue? Maybe we need to look at the societal pressures that promote unhealthy living in the first place. What’s going to happen when Ozempic demand outpaces supply, or when food prices stabilize? We might just see these rates climb again if we don’t shift our focus to real, sustainable lifestyle changes.”